Statement of Organization, Functions, and Delegations of Authority, 25809-25810 [2019-11548]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 107 / Tuesday, June 4, 2019 / Notices
A. OMB Number, Title, and any
Associated Form(s)
9000–0029, Extraordinary Contractual
Action Requests.
DEPARTMENT OF DEFENSE
GENERAL SERVICES
ADMINISTRATION
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[OMB Control No. 9000–0029; Docket No.
2019–0003; Sequence No. 13]
Information Collection; Extraordinary
Contractual Action Requests
Department of Defense (DOD),
General Services Administration (GSA),
and National Aeronautics and Space
Administration (NASA).
ACTION: Notice and request for
comments.
AGENCY:
In accordance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995, and the Office of
Management and Budget (OMB)
regulations, DoD, GSA, and NASA
invite the public to comment on a
revision concerning extraordinary
contractual action requests.
DATES: DoD, GSA, and NASA will
consider all comments received by
August 5, 2019.
ADDRESSES: DoD, GSA, and NASA
invite interested persons to submit
comments on this collection by either of
the following methods:
• Federal eRulemaking Portal: This
website provides the ability to type
short comments directly into the
comment field or attach a file for
lengthier comments. Go to https://
www.regulations.gov and follow the
instructions on the site.
• Mail: General Services
Administration, Regulatory Secretariat
Division (MVCB), 1800 F Street NW,
Washington, DC 20405. ATTN: Lois
Mandell/IC 9000–0029, Extraordinary
Contractual Action Requests.
Instructions: All items submitted
must cite Information Collection 9000–
0029. Comments received generally will
be posted without change to https://
www.regulations.gov, including any
personal and/or business confidential
information provided. To confirm
receipt of your comment(s), please
check www.regulations.gov,
approximately two-to-three days after
submission to verify posting (except
allow 30 days for posting of comments
submitted by mail).
FOR FURTHER INFORMATION CONTACT: Ms.
Cecelia L. Davis, Procurement Analyst,
Office of Governmentwide Acquisition
Policy, GSA, at 202–219–0202 or email
at cecelia.davis@gsa.gov.
SUPPLEMENTARY INFORMATION:
khammond on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:16 Jun 03, 2019
Jkt 247001
B. Needs and Uses
FAR subpart 50.1 prescribes policies
and procedures that allow contracts to
be entered into, amended, or modified
in order to facilitate national defense
under the extraordinary emergency
authority granted under 50 U.S.C. 1431
et seq. and Executive Order (E.O.) 10789
dated November 14, 1958, et seq.
This authority applies to the
Government Printing Office; the
Department of Homeland Security; the
Tennessee Valley Authority; the
National Aeronautics and Space
Administration; the Department of
Defense; the Department of the Army;
the Department of the Navy; the
Department of the Air Force; the
Department of the Treasury; the
Department of the Interior; the
Department of Agriculture; the
Department of Commerce; and the
Department of Transportation. Also
included is the Department of Energy
for functions transferred to that
Department from other authorized
agencies and any other agency that may
be authorized by the President.
In order for a contractor to be granted
relief under the FAR, specific evidence
must be submitted which supports the
firm’s assertion that relief is appropriate
and that the matter cannot be disposed
of under the terms of the contract.
FAR 50.103–3 specifies the minimum
information that a contractor must
include in a request for contract
adjustment in accordance with FAR 50–
103–1 and 50.103–2.
FAR 50–103–4 sets forth additional
information that the contracting officer
or other agency official may request
from the contractor to support any
request made under FAR 50.103–3.
FAR 50.104–3 sets forth the
information that the contractor shall
include in a request for the
indemnification clause to cover
unusually hazardous or nuclear risks.
FAR 52.250–1, Indemnification under
Public Law 850804, requires in
paragraph (g) that the contractor shall
promptly notify the contracting officer
of any claim or action against, or loss
by, the contractor or any subcontractors
that may reasonably to involve
indemnification under the clause.
The information is used by the
Government to determine if relief can be
granted under FAR and to determine the
appropriate type and amount of relief.
C. Annual Reporting Burden
Respondents: 28.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
25809
Total Annual Responses: 164.
Obtaining Copies: Requester may
obtain a copy of the information
collection documents from the General
Services Administration, Regulatory
Secretariat Division (MVCB), 1800 F
Street NW, Washington, DC 20405,
telephone 202–501–4755. Please cite
OMB Control No. 9000–0029,
Extraordinary Contractual Action
Requests, in all correspondence.
Dated: May 30, 2019.
Janet Fry,
Director, Federal Acquisition Policy Division,
Office of Governmentwide Acquisition Policy,
Office of Acquisition Policy, Office of
Governmentwide Policy.
[FR Doc. 2019–11622 Filed 6–3–19; 8:45 am]
BILLING CODE 6820–EP–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 84 FR 14739–14381,
dated April 10, 2019) is amended to
reflect the reorganization of the Office of
the Associate Director for Policy and
Strategy, Office of the Director, Centers
for Disease Control and Prevention. This
reorganization abolishes the Office of
Health System Collaboration and
establishes the Office of Population
Health and Healthcare.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the functional
statement for the Office of the Associate
Director for Policy and Strategy (CAQ),
and insert the following:
Office of the Associate Director for
Policy and Strategy (CAQ). The mission
of CDC’s Office of the Associate Director
for Policy and Strategy (OADPS) is to
bring about, define and evaluate policies
and strategies that result in
demonstrable improvements in public
health—globally and at the federal,
state, and local levels. In carrying out its
mission, OADPS: (1) Provides advice to
CDC leadership in developing agency
policies, programs, and strategies; (2)
creates and maintains partnerships to
implement policies, programs, and
E:\FR\FM\04JNN1.SGM
04JNN1
khammond on DSKBBV9HB2PROD with NOTICES
25810
Federal Register / Vol. 84, No. 107 / Tuesday, June 4, 2019 / Notices
strategies; (3) monitors and evaluates
programs to improve the public’s health;
and (4) ensures the agency’s scientific
credibility, reputation, and needs are
respected and supported by policy
makers, program partners, and
stakeholders.
Delete in its entirety the functional
statement for the Office of the Director
(CAQ1), and insert the following:
Office of the Director (CAQ1). (1)
Provides strategic advice to CDC
leadership on agency direction and
drives CDC towards actions to reduce
leading preventable causes of morbidity
and mortality; (2) ensures effectiveness
of policy, program, performance, and
strategy across the agency; (3) builds
capacity throughout CDC for policy,
program, performance, and strategy; (4)
leads the development and management
of policy and programmatic agendas
with federal agencies and other
organizations; (5) establishes and
maintains strategic partnerships with
key organizations and individuals
working on public health policies and
programs.
Delete in its entirety the title and
functional statement for the Office of
Health System Collaboration (CAQ12).
Delete in its entirety the functional
statement for the Policy Research,
Analysis, and Development Office
(CAQB), and insert the following:
Policy Research, Analysis, and
Development Office (CAQB). (1)
Identifies and assists CDC leadership in
informing policy at multiple levels (e.g.,
federal, state, local, global, and private
sector); (2) gathers and disseminates
knowledge about statutes, regulations,
and sub-regulatory guidance that can
increase the policy impact of CDC
programs; (3) conducts analyses,
including regulatory, legal, and
economic and develops strategies for
CDC policy priorities; (4) supports
policy implementation through the
provision of expertise, guidance,
reviews, and tools; (5) monitors and
evaluates the impact of CDC policies; (6)
builds policy analysis and development
capacity within CDC and the larger
public health community; (7) leads
CDC’s public health policy research
agenda; (8) manages selected partner
cooperative agreements and contracts
that focus on policy; and (9) incubates
innovative programs that emerge from
policy priorities identified by CDC
leadership.
Delete in its entirety the Program
Performance and Evaluation Office
(CAQD) and insert the following:
Program Performance and Evaluation
Office (CAQD). (1) Serves as an advisor
to CDC leadership on program
effectiveness to guide science, policy,
VerDate Sep<11>2014
17:16 Jun 03, 2019
Jkt 247001
and programmatic efforts; (2) provides
agency-wide direction, standards, and
technical assistance for program
planning, performance and
accountability; (3) supports the
harmonization of performance
measurement, accountability, and
program evaluation; (4) guides the
collection and analysis of economic,
performance, and accountability data;
(5) facilitates continuous improvement
based on program evaluation and
performance measurement; (6) manages
the CDC evaluation fellowship; (7)
provides economic evaluation support
to CDC leadership; (8) drives short-term
and long-term strategic program
planning; (9) supports evidence-driven
program design with expertise, analyses,
and tools; (10) promotes standardization
of shared programmatic activities to
improve efficiency; (11) coordinates
action planning for high impact
initiatives; and (12) facilitates
information sharing and collaboration
between programs and CDC leadership.
After the functional statement for the
Program Performance and Evaluation
Office (CAQD), insert the following:
Office of Population Health and
Healthcare (CAQE). (1) Engages multisectoral partners (e.g., private sector,
non-profit, transportation, housing,
healthcare providers and insurance
plans, foundations) to create
collaborative opportunities that improve
health outcomes; (2) uses data, subject
matter expertise and convening power
to inform the development of policies,
programs and tools; (3) provides agency
wide guidance on approaches and
partners that can help achieve CDC
aims; (4) builds capacity to use CDC
data analysis and interpretation
expertise to explore gaps in health
outcomes and develop population
health/healthcare solutions; and (5)
creates linkages and synergies between
CDC programs to maximize population
health impact.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–11548 Filed 6–3–19; 8:45 am]
BILLING CODE 4160–18–P
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10697]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
August 5, 2019.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
SUMMARY:
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 84, Number 107 (Tuesday, June 4, 2019)]
[Notices]
[Pages 25809-25810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-11548]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 84 FR 14739-14381, dated April 10, 2019) is
amended to reflect the reorganization of the Office of the Associate
Director for Policy and Strategy, Office of the Director, Centers for
Disease Control and Prevention. This reorganization abolishes the
Office of Health System Collaboration and establishes the Office of
Population Health and Healthcare.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the functional statement for the Office of
the Associate Director for Policy and Strategy (CAQ), and insert the
following:
Office of the Associate Director for Policy and Strategy (CAQ). The
mission of CDC's Office of the Associate Director for Policy and
Strategy (OADPS) is to bring about, define and evaluate policies and
strategies that result in demonstrable improvements in public health--
globally and at the federal, state, and local levels. In carrying out
its mission, OADPS: (1) Provides advice to CDC leadership in developing
agency policies, programs, and strategies; (2) creates and maintains
partnerships to implement policies, programs, and
[[Page 25810]]
strategies; (3) monitors and evaluates programs to improve the public's
health; and (4) ensures the agency's scientific credibility,
reputation, and needs are respected and supported by policy makers,
program partners, and stakeholders.
Delete in its entirety the functional statement for the Office of
the Director (CAQ1), and insert the following:
Office of the Director (CAQ1). (1) Provides strategic advice to CDC
leadership on agency direction and drives CDC towards actions to reduce
leading preventable causes of morbidity and mortality; (2) ensures
effectiveness of policy, program, performance, and strategy across the
agency; (3) builds capacity throughout CDC for policy, program,
performance, and strategy; (4) leads the development and management of
policy and programmatic agendas with federal agencies and other
organizations; (5) establishes and maintains strategic partnerships
with key organizations and individuals working on public health
policies and programs.
Delete in its entirety the title and functional statement for the
Office of Health System Collaboration (CAQ12).
Delete in its entirety the functional statement for the Policy
Research, Analysis, and Development Office (CAQB), and insert the
following:
Policy Research, Analysis, and Development Office (CAQB). (1)
Identifies and assists CDC leadership in informing policy at multiple
levels (e.g., federal, state, local, global, and private sector); (2)
gathers and disseminates knowledge about statutes, regulations, and
sub-regulatory guidance that can increase the policy impact of CDC
programs; (3) conducts analyses, including regulatory, legal, and
economic and develops strategies for CDC policy priorities; (4)
supports policy implementation through the provision of expertise,
guidance, reviews, and tools; (5) monitors and evaluates the impact of
CDC policies; (6) builds policy analysis and development capacity
within CDC and the larger public health community; (7) leads CDC's
public health policy research agenda; (8) manages selected partner
cooperative agreements and contracts that focus on policy; and (9)
incubates innovative programs that emerge from policy priorities
identified by CDC leadership.
Delete in its entirety the Program Performance and Evaluation
Office (CAQD) and insert the following:
Program Performance and Evaluation Office (CAQD). (1) Serves as an
advisor to CDC leadership on program effectiveness to guide science,
policy, and programmatic efforts; (2) provides agency-wide direction,
standards, and technical assistance for program planning, performance
and accountability; (3) supports the harmonization of performance
measurement, accountability, and program evaluation; (4) guides the
collection and analysis of economic, performance, and accountability
data; (5) facilitates continuous improvement based on program
evaluation and performance measurement; (6) manages the CDC evaluation
fellowship; (7) provides economic evaluation support to CDC leadership;
(8) drives short-term and long-term strategic program planning; (9)
supports evidence-driven program design with expertise, analyses, and
tools; (10) promotes standardization of shared programmatic activities
to improve efficiency; (11) coordinates action planning for high impact
initiatives; and (12) facilitates information sharing and collaboration
between programs and CDC leadership.
After the functional statement for the Program Performance and
Evaluation Office (CAQD), insert the following:
Office of Population Health and Healthcare (CAQE). (1) Engages
multi-sectoral partners (e.g., private sector, non-profit,
transportation, housing, healthcare providers and insurance plans,
foundations) to create collaborative opportunities that improve health
outcomes; (2) uses data, subject matter expertise and convening power
to inform the development of policies, programs and tools; (3) provides
agency wide guidance on approaches and partners that can help achieve
CDC aims; (4) builds capacity to use CDC data analysis and
interpretation expertise to explore gaps in health outcomes and develop
population health/healthcare solutions; and (5) creates linkages and
synergies between CDC programs to maximize population health impact.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-11548 Filed 6-3-19; 8:45 am]
BILLING CODE 4160-18-P
